18.79
price down icon1.52%   -0.2475
 
loading
Fulgent Genetics Inc stock is traded at $18.79, with a volume of 8,202. It is down -1.52% in the last 24 hours and up +9.97% over the past month. Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
See More
Previous Close:
$19.04
Open:
$18.95
24h Volume:
8,202
Relative Volume:
0.02
Market Cap:
$551.26M
Revenue:
$290.71M
Net Income/Loss:
$-163.43M
P/E Ratio:
-3.4293
EPS:
-5.48
Net Cash Flow:
$11.70M
1W Performance:
+4.98%
1M Performance:
+9.97%
6M Performance:
-3.45%
1Y Performance:
-6.39%
1-Day Range:
Value
$18.68
$18.95
1-Week Range:
Value
$17.63
$19.32
52-Week Range:
Value
$14.76
$25.11

Fulgent Genetics Inc Stock (FLGT) Company Profile

Name
Name
Fulgent Genetics Inc
Name
Phone
626-350-0537
Name
Address
4399 SANTA ANITA AVE, EL MONTE
Name
Employee
1,313
Name
Next Earnings Date
2024-11-08
Name
Latest SEC Filings
Name
FLGT's Discussions on Twitter

Compare FLGT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
FLGT
Fulgent Genetics Inc
18.83 551.26M 290.71M -163.43M 11.70M -5.48
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
418.78 161.38B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
194.69 133.67B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
437.20 33.35B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
A
Agilent Technologies Inc
105.12 29.22B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
147.46 25.37B 15.41B 1.37B 2.11B 7.50

Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-07-23 Initiated UBS Neutral
Dec-08-22 Downgrade Piper Sandler Overweight → Neutral
Nov-18-22 Initiated Raymond James Outperform
Aug-25-22 Initiated Credit Suisse Outperform
Feb-04-22 Resumed Piper Sandler Overweight
Aug-05-21 Resumed Credit Suisse Underperform
Jan-08-21 Downgrade Credit Suisse Neutral → Underperform
Nov-24-20 Downgrade BTIG Research Buy → Neutral
Aug-20-20 Initiated Oppenheimer Outperform
May-29-20 Initiated BTIG Research Buy
Nov-05-19 Upgrade Piper Jaffray Neutral → Overweight
Mar-01-18 Downgrade Piper Jaffray Overweight → Neutral
Nov-07-17 Downgrade Raymond James Outperform → Mkt Perform
View All

Fulgent Genetics Inc Stock (FLGT) Latest News

pulisher
Apr 24, 2025

Geode Capital Management LLC Grows Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Apr 24, 2025
pulisher
Apr 21, 2025

Fulgent Genetics Inc (FLGT) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance

Apr 21, 2025
pulisher
Apr 20, 2025

JPMorgan Chase & Co. Raises Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Apr 20, 2025
pulisher
Apr 19, 2025

Vanguard Group Inc. Decreases Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Apr 19, 2025
pulisher
Apr 16, 2025

Inlight Wealth Management LLC Purchases New Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Apr 16, 2025
pulisher
Apr 15, 2025

Vanguard Group Inc. Has $25.69 Million Stock Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

ExodusPoint Capital Management LP Purchases 39,618 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Apr 14, 2025
pulisher
Apr 13, 2025

Fulgent Genetics, Inc. (NASDAQ:FLGT) Holdings Trimmed by Corebridge Financial Inc. - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

Strong week for Fulgent Genetics (NASDAQ:FLGT) shareholders doesn't alleviate pain of three-year loss - simplywall.st

Apr 12, 2025
pulisher
Apr 12, 2025

KLP Kapitalforvaltning AS Takes $57,000 Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

American Century Companies Inc. Buys 4,262 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Bought by Trexquant Investment LP - MarketBeat

Apr 12, 2025
pulisher
Apr 11, 2025

Fulgent Genetics (NASDAQ:FLGT) shareholders have endured a 69% loss from investing in the stock three years ago - Yahoo

Apr 11, 2025
pulisher
Apr 11, 2025

Fulgent to Announce First Quarter 2025 Financial Results on Friday, May 2, 2025 - BioSpace

Apr 11, 2025
pulisher
Apr 10, 2025

Fulgent to Announce First Quarter 2025 Financial Results on Frid - GuruFocus

Apr 10, 2025
pulisher
Apr 10, 2025

Fulgent Q1 2025 Earnings: Key Date and Access Details Revealed - Stock Titan

Apr 10, 2025
pulisher
Apr 10, 2025

Prudential Financial Inc. Has $383,000 Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Apr 10, 2025
pulisher
Apr 09, 2025

Fragile X Syndrome Genetic Testing Market to Get a New Boost | Gene Dx, Fulgent Genetics - newstrail.com

Apr 09, 2025
pulisher
Apr 08, 2025

Fulgent Genetics, Inc. (NASDAQ:FLGT) Short Interest Up 19.6% in March - MarketBeat

Apr 08, 2025
pulisher
Apr 07, 2025

Sei Investments Co. Decreases Stock Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Apr 07, 2025
pulisher
Apr 05, 2025

38,818 Shares in Fulgent Genetics, Inc. (NASDAQ:FLGT) Bought by Diametric Capital LP - MarketBeat

Apr 05, 2025
pulisher
Apr 04, 2025

FLGT 6-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Fulgent Genetics (FLGT) Investors with Significant Losses to Contact the Firm’s Attorneys Before Nov. 21st Deadline in Securities Class Action - ACCESS Newswire

Apr 04, 2025
pulisher
Mar 31, 2025

Quantbot Technologies LP Has $192,000 Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Mar 31, 2025
pulisher
Mar 31, 2025

Where are the Opportunities in (FLGT) - news.stocktradersdaily.com

Mar 31, 2025
pulisher
Mar 30, 2025

Charles Schwab Investment Management Inc. Has $3.88 Million Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 30, 2025
pulisher
Mar 29, 2025

Proficio Capital Partners LLC Purchases New Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 29, 2025
pulisher
Mar 28, 2025

PNC Financial Services Group Inc. Sells 2,046 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Bought by Intech Investment Management LLC - MarketBeat

Mar 27, 2025
pulisher
Mar 27, 2025

Magnetar Financial LLC Buys Shares of 16,977 Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 27, 2025
pulisher
Mar 25, 2025

A better buy-in window may exist right now for Fulgent Genetics Inc (FLGT) - SETE News

Mar 25, 2025
pulisher
Mar 25, 2025

22,238 Shares in Fulgent Genetics, Inc. (NASDAQ:FLGT) Acquired by Proficio Capital Partners LLC - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

Bank of New York Mellon Corp Sells 38,099 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 24, 2025
pulisher
Mar 23, 2025

Connor Clark & Lunn Investment Management Ltd. Purchases 112,011 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 23, 2025
pulisher
Mar 22, 2025

Fulgent Genetics Inc (FLGT) Shares Up 1.18% on Mar 22 - GuruFocus.com

Mar 22, 2025
pulisher
Mar 22, 2025

Amundi Boosts Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Mar 22, 2025

Fulgent Genetics Inc Stock (FLGT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research LH
$228.47
price down icon 0.28%
diagnostics_research DGX
$175.85
price up icon 0.10%
diagnostics_research WAT
$333.81
price down icon 1.84%
$153.52
price down icon 0.23%
diagnostics_research MTD
$1,048.78
price down icon 3.58%
diagnostics_research IQV
$146.97
price down icon 2.30%
Cap:     |  Volume (24h):